STOCKS TO BUY: We have identified several stocks that can potentially TRIPLE. Learn more!

Hemispherx Biopharma Inc. (HEB)

AMEX: Health Care

Get a 5-page Ratings Report on (HEB) now
$0.25 0.00 | -1.40%
Today's Range: 0.24 - 0.25
HEB Avg. Daily Volume: 805,400
06/19/13 - 10:55 AM ET
 
  • Latest Dividend: N/A
  • Latest Dividend Yield: N/A
  • Dividend Ex-Date: N/A
  • Price Earnings Ratio: -2.08
  • Price Earnings Comparisons:
    HEB Sector Avg. S&P 500
    -2.08 0.00 17.70
  • Price Performance History
    (% change):
    3 Mo 1 Yr 3 Yr
    19.05% -12.61% -56.14%
  • GROWTH 12 Mo 3 Yr CAGR
    Revenue 32.30 0.92 0.24
    Net Income 0.00 0.29 0.00
    EPS 0.00 0.00 0.00
  • Earnings for HEB:
    EBITDA -19,657,000
    REVENUE 213,000
Average Earnings Estimates
Qtr (06/13) Qtr (09/13) FY (12/13) FY (12/14)
Average Estimate $n.a. $n.a. $n.a. $n.a.
Number of Analysts 0 0 0 0
High Estimate $n.a. $n.a. $n.a. $n.a.
Low Estimate $n.a. $n.a. $n.a. $n.a.
Prior Year $-0.02 $-0.03 $-0.11 $n.a.
Growth Rate (Year over Year) n.a.% n.a.% n.a.% n.a.%
(HEB) News
More (HEB) News
(HEB) Partner Headlines

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
TRY IT FREE
New! $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 15,295.19 -23.04 -0.15%
NASDAQ 3,480.65 -1.53 -0.04%
S&P 500 1,650.21 -1.60 -0.10%
US 10 Yr 2.189% +0.007

Brokerage Partners
Advertising Partners

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Manage Newsletters

Top Rated Stocks Top Rated Funds Top Rated ETFs